^™middle.

Gathering signals...

Vita Life Sciences (ASX:VLS) — Material Events

ASX:VLS · 5 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed

Significant Score 75–89

4

Vita Life Sciences Delivers Record Revenue and Profit in FY2025Medium

Vita Life Sciences posts record FY2025 revenue and profit, declares 14.0 cents dividend

16 Feb 2026 ·Preliminary Final Report ·85

Vita Life Sciences Boosts Revenue 15% and Raises Dividend Amid Regional GrowthMedium

Vita Life Sciences posts 15% revenue growth and raises interim dividend to 4.5 cents

25 Aug 2025 ·Appendix 4D - Half Year Report ·85

Vita Life Sciences Posts Record Revenue, Eyes Continued Growth in Asia-PacificMedium

Vita Life Sciences H1 2025: Record Revenue, Strong Profit, Dividend Up, Growth Across Asia-Pacific

25 Aug 2025 ·Half Year Presentation ·80

Vita Life Sciences Projects Robust FY2025 Growth Led by Malaysia and SingaporeMedium

Vita Life Sciences FY2025 guidance projects sales growth to $91m-$92m and pre-tax profit up to $13.7m

12 Dec 2025 ·FY2025 Guidance ·75

Notable Score 50–74

1

Vita Life Sciences Forecasts Modest Growth Amid China Export ChallengesMedium

Vita Life Sciences forecasts modest revenue growth and stable profit for H1 2026

12 June 2026 ·Guidance ·60

Not Assessed Low Score, or missing data

0

No articles in this tier for the last 12 months.

Market Mentions 3 - appeared in market wrap coverage

These are market wrap articles where Vita Life Sciences (ASX:VLS) was mentioned. They reflect broader market coverage, not company-specific announcements.

Healthcare Wrap - Week 24 (8 June -> 12 June) 2026

Market Wrap - Week 8 (16 Feb -> 20 Feb) 2026

Healthcare Wrap - Week 8 (16 Feb -> 20 Feb) 2026